Investing.com - Jubilant Pharmova reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.
Jubilant Pharmova announced earnings per share of ₹0.34 on revenue of ₹16.00. Analysts polled by Investing.com anticipated EPS of ₹9.95 on revenue of ₹15.01B.
Jubilant Pharmova shares are down 42.55% from the beginning of the year, still down 46.17% from its 52 week high of ₹626.00 set on November 9, 2021.
Jubilant Pharmova follows other major Healthcare sector earnings this month
Jubilant Pharmova's report follows an earnings missed by Syngene International Ltd on October 20, who reported EPS of ₹2.53 on revenue of ₹7.68B, compared to forecasts EPS of ₹2.65 on revenue of ₹7.21B.
Granules India had beat expectations on October 20 with second quarter EPS of ₹5.82 on revenue of ₹11.51B, compared to forecast for EPS of ₹5.2 on revenue of ₹10.71B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar